394 related articles for article (PubMed ID: 23109759)
1. AMPLATZER Septal Occluder failure resulting in paradoxical cerebral embolism.
Fernando RR; Koranne KP; Barker CM
Tex Heart Inst J; 2012; 39(5):647-52. PubMed ID: 23109759
[TBL] [Abstract][Full Text] [Related]
2. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
Luna M; Banerjee S; Brilakis ES
Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
[TBL] [Abstract][Full Text] [Related]
3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
4. [Interventional occlusion of foramen ovale and atrial septal defects after paradoxical embolism incidents].
Beitzke A; Schuchlenz H; Beitzke M; Gamillscheg A; Stein HI; Zartner P
Z Kardiol; 2002 Sep; 91(9):693-700. PubMed ID: 12448068
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter retrieval of embolized AMPLATZER Septal Occluder.
Goel PK; Kapoor A; Batra A; Khanna R
Tex Heart Inst J; 2012; 39(5):653-6. PubMed ID: 23109760
[TBL] [Abstract][Full Text] [Related]
6. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
[TBL] [Abstract][Full Text] [Related]
8. Embolized Amplatzer septal occluder device presenting with ventricular fibrillation.
Yuce M; Ozer O; Cakici M; Cine N; Sari I; Davutoglu V
Cardiovasc Revasc Med; 2011; 12(2):131-2. PubMed ID: 21421193
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous closure of atrial right-to-left shunt in patients with Ebstein's anomaly of the tricuspid valve.
Silva M; Teixeira A; Menezes I; Nogueira G; Ferreira R; Maymone-Martins F; Anjos R
EuroIntervention; 2012 May; 8(1):94-7. PubMed ID: 22580253
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
[TBL] [Abstract][Full Text] [Related]
12. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following transcatheter device placement.
Hung J; Landzberg MJ; Jenkins KJ; King ME; Lock JE; Palacios IF; Lang P
J Am Coll Cardiol; 2000 Apr; 35(5):1311-6. PubMed ID: 10758974
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
14. Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.
Becker M; Frings D; Schröder J; Ocklenburg C; Mühler E; Hoffmann R; Franke A; Lepper W
J Interv Cardiol; 2009 Dec; 22(6):503-10. PubMed ID: 19821880
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of possible paradoxical embolic events in adults with ebstein anomaly and severe tricuspid regurgitation.
Attenhofer Jost CH; Connolly HM; Scott CG; Burkhart HM; Ammash NM; Dearani JA
Congenit Heart Dis; 2014; 9(1):30-7. PubMed ID: 23601093
[TBL] [Abstract][Full Text] [Related]
16. Defect closure in the lipomatous hypertrophied atrial septum with the Amplatzer muscular ventricular septal defect closure device: a case series.
Lin CH; Balzer DT; Lasala JM
Catheter Cardiovasc Interv; 2011 Jul; 78(1):102-7. PubMed ID: 21416575
[TBL] [Abstract][Full Text] [Related]
17. Embolization of patent foramen ovale closure devices: incidence, role of imaging in identification, potential causes, and management.
Goel SS; Aksoy O; Tuzcu EM; Krasuski RA; Kapadia SR
Tex Heart Inst J; 2013; 40(4):439-44. PubMed ID: 24082375
[TBL] [Abstract][Full Text] [Related]
18. Rare case of pulmonary arteriovenous fistula simulating residual defect after transcatheter closure of patent foramen ovale for recurrent paradoxical embolism.
Peters B; Ewert P; Schubert S; Abdul-Khaliq H; Lange PE
Catheter Cardiovasc Interv; 2005 Mar; 64(3):348-51. PubMed ID: 15736259
[TBL] [Abstract][Full Text] [Related]
19. Thrombus formation during percutaneous closure of an atrial septal defect with an Amplatzer septal occluder.
Yorgun H; Canpolat U; Kaya EB; Aytemir K; Oto A
Tex Heart Inst J; 2011; 38(4):427-30. PubMed ID: 21841876
[TBL] [Abstract][Full Text] [Related]
20. Ischemic stroke caused by paradoxical embolism after an unsuccessful transcatheter atrial septal defect closure procedure: a word of caution.
Fang ZF; Tang L; Zhou SH
Pediatr Cardiol; 2012 Feb; 33(2):366-9. PubMed ID: 22120514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
